Clinical Trials Logo

Hysterectomy clinical trials

View clinical trials related to Hysterectomy.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06455540 Not yet recruiting - Hysterectomy Clinical Trials

SUperior Hypogastric Plexus Block During Laparoscopic hysterEctomy (SUBTLE)

SUBTLE
Start date: July 16, 2024
Phase: N/A
Study type: Interventional

This trial sest to assess the efficacy of a superior hypogastric plexus block (SHPB) for quality of recovery after a laparoscopic hysterectomy.

NCT ID: NCT06011538 Not yet recruiting - Hysterectomy Clinical Trials

Web-based Versus Standard Information for Same Day Hysterectomy (WISH)

WISH
Start date: September 2023
Phase: N/A
Study type: Interventional

Objectives: To evaluate the potential utility and efficacy of additional on-line, patient education resource for same day discharge following laparoscopic hysterectomy (SDD LH) compared to standard information resources alone Trial Design: A pilot, parallel, open, single centre, randomised controlled trial Participant Population and Sample Size: 40 women undergoing SDD LH for a benign reason Eligibility Criteria: Women with gynaecological conditions requiring a laparoscopic hysterectomy (LH) and who are suitable for same day discharge (SDD). Interventions: An online patient education website resource and the comparator is standard practice for provision of patient information (written and verbal). Outcome Measures: Primary - Compliance with SDD Secondary - In Hospital: o Surgical details / complexity / intraoperative and post-operative serious adverse events (SAEs) according to the Clavien-Dindo system grade II-IV which is a widely used index for the classification of surgical complications [case notes and electronic patient record], and time to discharge - 6 weeks: - Satisfaction, acceptability and utility of patient education / information provided (bespoke patient questionnaire; Likert scales) - Satisfaction with care after LH (6-point Likert) - Generic quality of life at 6 weeks post-surgery (EuroQol-5D-5L and VAS); - Contact with Community & Clinical Care Services i.e. outpatients or emergency visits, re-presentations / re-admissions to hospital (Case report form [CRF], case notes, electronic patient record) - Serious Adverse Events (CRF, case notes, electronic patient record) - Time from surgery to resumption of usual activities using the PROMIS-SF (Patient-Reported Outcomes Measurement Information System Physical Function) questionnaire (Modified items / response categories) - 12 weeks: - Time from surgery to resumption of usual activities using the PROMIS-SF (Patient-Reported Outcomes Measurement Information System Physical Function) questionnaire (Modified items / response categories) Time to return to work (if working)

NCT ID: NCT05481606 Not yet recruiting - Hysterectomy Clinical Trials

Cesarean Scar Pregnancy and Clinical Outcomes

Start date: August 1, 2022
Phase:
Study type: Observational [Patient Registry]

This study is a prospective cohort study, led by Prof. Zhao Yangyu, from the Department of Gynecology & Obstetrics, Peking University Third Hospital.

NCT ID: NCT05421156 Not yet recruiting - Hysterectomy Clinical Trials

Long-term Outcomes After Laparoscopic Subtotal and Total Hysterectomy

LAST-1
Start date: July 2024
Phase:
Study type: Observational

Hysterectomy is one of the most commonly performed gynecologic surgeries in the USA. It is used for many benign conditions such as leiomyoma and abnormal uterine bleeding. Surgery may involve the removal of the cervix (total hysterectomy, TH) or its preservation (supracervical or subtotal hysterectomy, SH). Whether TH or SH is the best procedure for benign conditions is a matter of debate. Considering the lack of evidence, this study aims to evaluate long-term sexual dysfunctions, urinary dysfunctions and pelvic organ prolapse in women who underwent laparoscopic subtotal versus total hysterectomy for benign conditions.

NCT ID: NCT03917134 Not yet recruiting - Hysterectomy Clinical Trials

Prevention of Vaginal Cellulitis or Vaginal Cuff Abscess After Laparoscopic Hysterectomy

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

Operative site infection remains the most common complication after performing a gynecological procedure, and has a great implication in the morbidity and mortality of patients. Gynecological procedures, including laparoscopic hysterectomy, represent a unique challenge due to the amount of microorganisms found at the skin level of the vagina or the endocervix. However, there is no clear evidence that the complication decreases with the use of postoperative antibiotics. With the completion of this study, a multicentre triple-blind controlled randomized controlled trial is intended to determine the behavior of the application of this intervention. Patients who attend an outpatient clinic with benign pathology will be selected, in which indication of laparoscopic hysterectomy, consents are completed and research content is widely explained. Prior to surgery, the sample is taken for a gram of vaginal discharge and in the post-surgical phase delivery of the medication will be performed. Follow-up will be carried out by surgical control and by telephone. The investigator intend to find that with the prophylaxis not only of presurgical cephalosporin, but with the formulation of metronidazole ovules in the postoperative, the incidence of laparoscopic post-hysterectomy vaginal abscess and cellulitis of cuff is reduced.

NCT ID: NCT02998658 Not yet recruiting - Hysterectomy Clinical Trials

Barbed Versus Conventional Sutures for Vaginal Cuff Closure During Total Laparoscopic Hysterectomy

Start date: February 2017
Phase: Phase 2
Study type: Interventional

The aim of this study is to estimate whether the use of the barbed suture facilitates laparoscopic suturing of the vaginal cuff during total laparoscopic hysterectomy.